MicroRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R

International Journal of Oncology

Volumn 45, Issue 4, 2014, Pages 1437-1449

  Han, Kang ^a,b   Zhao, Tingbao ^b   Chen, Xiang ^c   Bian, Na ^a   Yang, Tongtao ^a   Ma, Qiong ^a   Cai, Chengkui ^a   Fan, Qingyu ^a   Zhou, Yong ^a   Ma, Baoan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b JINAN MILITARY GENERAL HOSPITAL   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

CDH2; IGF1R; Metastasis; miR 194; Osteosarcoma; Proliferation

Indexed keywords

FORMALDEHYDE; MICRORNA; MICRORNA 194; NERVE CELL ADHESION MOLECULE; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; CADHERIN; CDH2 PROTEIN, HUMAN; IGF1R PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MIRN194 MICRORNA, HUMAN; SOMATOMEDIN RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE METASTASIS; CANCER INHIBITION; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRINAE; LUCIFERASE ASSAY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OSTEOSARCOMA CELL LINE; PRIORITY JOURNAL; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME; U2OS CELL LINE; WESTERN BLOTTING; ANIMAL; BONE TUMOR; CANCER TRANSPLANTATION; GENETICS; LUNG TUMOR; METABOLISM; METASTASIS; NUDE MOUSE; OSTEOSARCOMA; PATHOLOGY; SECONDARY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD; BONE NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; OSTEOSARCOMA; RECEPTORS, SOMATOMEDIN;

EID: 84907465488     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2571     Document Type: Article

References (51)

1. Mirabello L, Troisi RJ and Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 115: 1531-1543, 2009.
2. Marina N, Gebhardt M, Teot L and Gorlick R: Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9: 422-441, 2004. (Pubitemid 39014554)
3. Picci P: Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis 2: 6, 2007.
4. Ambros V: microRNAs: tiny regulators with great potential. Cell 107: 823-826, 2001.
5. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
6. Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854, 1993. (Pubitemid 24014542)
7. Sarver AL, Li L and Subramanian S: MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res 70: 9570-9580, 2010.
8. Gong C, Yao Y, Wang Y, et al: Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem 286: 19127-19137, 2011.
9. Mei J, Bachoo R and Zhang CL: MicroRNA-146a inhibits glioma development by targeting Notch1. Mol Cell Biol 31: 3584-3592, 2011.
10. Suh SS, Yoo JY, Nuovo GJ, et al: MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci USA 109: 5316-5321, 2012.
11. Qi P, Cheng SQ, Wang H, Li N, Chen YF and Gao CF: Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 6: e28486, 2011.
12. Dang X, Ma A, Yang L, et al: MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells. Cancer Genet 205: 113-123, 2012.
13. Suzuki H, Yamamoto E, Nojima M, et al: Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis 31: 2066-2073, 2010.
14. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
15. Saito Y, Liang G, Egger G, et al: Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9: 435-443, 2006. (Pubitemid 43832188)
16. Yan K, Gao J, Yang T, et al: MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS One 7: e33778, 2012.
17. Wu Q, Jin H, Yang Z, et al: MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun 392: 340-345, 2010.
18. Chow TF, Mankaruos M, Scorilas A, et al: The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. J Urol 183: 743-751, 2010.
19. Deng S, Calin GA, Croce CM, Coukos G and Zhang L: Mechanisms of microRNA deregulation in human cancer. Cell Cycle 7: 2643-2646, 2008.
20. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007. (Pubitemid 46096921)
21. Slaby O, Svoboda M, Fabian P, et al: Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402, 2007. (Pubitemid 351238155)
22. Kloosterman WP and Plasterk RH: The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450, 2006. (Pubitemid 44430905)
23. Hino K, Tsuchiya K, Fukao T, et al: Inducible expression of microRNA-194 is regulated by HNF-1α during intestinal epithelial cell differentiation. RNA 14: 1433-1442, 2008. (Pubitemid 351872199)
24. Meng Z, Fu X, Chen X, et al: miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology 52: 2148-2157, 2010.
25. Krutzfeldt J, Rosch N, Hausser J, Manoharan M, Zavolan M and Stoffel M: MicroRNA-194 is a target of transcription factor 1 (Tcf1, HNF1α) in adult liver and controls expression of frizzled-6. Hepatology 55: 98-107, 2012.
26. Le XF, Almeida MI, Mao W, et al: Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer. PLoS One 7: e41170, 2012.
27. Hino K, Fukao T and Watanabe M: Regulatory interaction of HNF1-α to microRNA-194 gene during intestinal epithelial cell differentiation. Nucleic Acids Symp Ser (Oxf) 51: 415-416, 2007.
28. Braun CJ, Zhang X, Savelyeva I, et al: p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 68: 10094-10104, 2008.
29. Song Y, Zhao F, Wang Z, et al: Inverse association between miR-194 expression and tumor invasion in gastric cancer. Ann Surg Oncol 19 (Suppl 3): S509-S517, 2012.
30. Dong P, Kaneuchi M, Watari H, et al: MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer 10: 99, 2011.
31. Pichiorri F, Suh SS, Rocci A, et al: Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 18: 367-381, 2010.
32. Chen X, Yang TT, Wang W, et al: Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials. Cytotechnology 61: 37-44, 2009.
33. Zhao G, Cai C, Yang T, et al: MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. PLoS One 8: e53906, 2013.
34. Sun D, Yang K, Zheng G, Li Z and Cao Y: Study on effect of peptide-conjugated near-infrared fluorescent quantum dots on the clone formation, proliferation, apoptosis, and tumorigenicity ability of human buccal squamous cell carcinoma cell line BcaCD885. Int J Nanomed 5: 401-405, 2010.
35. Naito S, von Eschenbach AC, Giavazzi R and Fidler IJ: Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res 46: 4109-4115, 1986. (Pubitemid 16075915)
36. Pan Z, Zhao W, Zhang X, et al: Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2. Br J Pharmacol 162: 688-700, 2011.
37. Osaki M, Takeshita F, Sugimoto Y, et al: MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther 19: 1123-1130, 2011.
38. Kong W, He L, Coppola M, et al: MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 285: 17869-17879, 2010.
39. Grenman R, Burk D, Virolainen E, et al: Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution. Int J Cancer 44: 131-136, 1989. (Pubitemid 19184689)
40. Arndt CA, Rose PS, Folpe AL and Laack NN: Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc 87: 475-487, 2012.
41. Bacci G, Rocca M, Salone M, et al: High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol 98: 415-420, 2008.
42. Baffa R, Fassan M, Volinia S, et al: MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 219: 214-221, 2009.
43. Lauvrak SU, Munthe E, Kresse SH, et al: Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer 109: 2228-2236, 2013.
44. Miretti S, Roato I, Taulli R, et al: A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging. PLoS One 3: e1828, 2008.
45. Angst BD, Marcozzi C and Magee AI: The cadherin superfamily: diversity in form and function. J Cell Sci 114: 629-641, 2001. (Pubitemid 32237135)
46. Stemmler MP: Cadherins in development and cancer. Mol Biosyst 4: 835-850, 2008.
47. Derycke LD and Bracke ME: N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Dev Biol 48: 463-476, 2004. (Pubitemid 39360397)
48. Dziadziuszko R, Merrick DT, Witta SE, et al: Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression. J Clin Oncol 28: 2174-2180, 2010.
49. Meyer F, Samson E, Douville P, Duchesne T, Liu G and Bairati I: Serum prognostic markers in head and neck cancer. Clin Cancer Res 16: 1008-1015, 2010.
50. Munagala R, Aqil F and Gupta RC: Promising molecular targeted therapies in breast cancer. Indian J Pharmacol 43: 236-245, 2011.
51. Griffiths-Jones S, Saini HK, van Dongen S and Enright AJ: miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-D158, 2008. (Pubitemid 351149713)